ID: ALA4794592

Max Phase: Preclinical

Molecular Formula: C29H42N4O13

Molecular Weight: 654.67

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  N[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3O[C@H](CNC(=O)c4ccc5cc(O)ccc5c4)[C@@H](O)[C@H](O)[C@H]3O)[C@@H](N)C[C@H]2N)O[C@H](CO)[C@H]1O

Standard InChI:  InChI=1S/C29H42N4O13/c30-14-7-15(31)26(24(41)25(14)45-28-21(38)18(32)19(36)17(9-34)44-28)46-29-23(40)22(39)20(37)16(43-29)8-33-27(42)12-2-1-11-6-13(35)4-3-10(11)5-12/h1-6,14-26,28-29,34-41H,7-9,30-32H2,(H,33,42)/t14-,15+,16-,17-,18+,19-,20-,21-,22+,23-,24-,25+,26-,28-,29-/m1/s1

Standard InChI Key:  JLNQQRMNBIMJLQ-GWFZJZCASA-N

Associated Targets(Human)

Gap junction beta-2 protein 74 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Gap junction alpha-1 protein 92 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 654.67Molecular Weight (Monoisotopic): 654.2748AlogP: -4.96#Rotatable Bonds: 8
Polar Surface Area: 305.92Molecular Species: BASEHBA: 16HBD: 12
#RO5 Violations: 3HBA (Lipinski): 17HBD (Lipinski): 15#RO5 Violations (Lipinski): 3
CX Acidic pKa: 9.94CX Basic pKa: 9.34CX LogP: -5.23CX LogD: -8.42
Aromatic Rings: 2Heavy Atoms: 46QED Weighted: 0.13Np Likeness Score: 0.96

References

1. Subedi YP,Kjellgren A,Roberts P,Montgomery H,Thackeray N,Fiori MC,Altenberg GA,Chang CT.  (2020)  Amphiphilic aminoglycosides with increased selectivity for inhibition of connexin 43 (Cx43) hemichannels.,  203  [PMID:32679454] [10.1016/j.ejmech.2020.112602]

Source